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Abstract
 
Interleukin (IL)-7 is a stromal cell–derived cytokine required for the survival, proliferation, and
differentiation of B cell precursors. Members of the Bcl-2 family of proteins are known to have
profound effects on lymphocyte survival, but not lymphocyte differentiation. To distinguish
the relative dependence on IL-7 of B cell precursor survival versus B cell differentiation, the
combined effects of lack of IL-7 and lack of the proapoptotic Bcl-2 relative, Bim, were studied.
Bim is expressed to varying degrees in all B cell precursors and B cells. Lack of Bim compen-
sated for lack of IL-7 in the survival of pro–, pre–, and immature B cells; however, lack of Bim
did not substitute for the requirement for IL-7 in B cell precursor differentiation or B cell pre-
cursor proliferation. Precursor B cell survival is more dependent on sufficient levels of IL-7
than precursor B cell differentiation because the number of B cells and their precursors were
reduced by half in mice heterozygous for IL-7 expression, but were restored to normal num-
bers in mice also lacking Bim. Hence, Bim and IL-7 work together to control the survival of B
cell precursors and the number of B cells that exist in animals.
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Introduction
 
B cell development from common lymphoid precursors
(CLPs) to mature B cells involves a series of differentiation
events. Thus, CLPs mature into pre-pro–B cells and then
pass sequentially through the pro– and pre–B cell stages,
eventually becoming immature B cells expressing, for the
first time at this stage, a fully fledged IgM protein (1–3).
For some of these events, the external signals that drive
these processes are either not known, or the process may
simply be programmed into the developing cell. The external
signals have been well defined for other steps. Chief
amongst these are processes driven by IL-7 (4, 5).
IL-7 is produced by stromal cells and epithelial cells in
various organs, including the bone marrow (4). It first came
to be recognized as a factor that might be important for B
cell development in experiments showing that IL-7 could
promote the proliferation and differentiation of B cell pro-
genitors in bone marrow cultures (6–8). Since then, many
different types of knockout and transgenic mice have added
to our knowledge of the effects of IL-7 on B cell develop-
ment (9–12). As a result, it is now thought that IL-7 is re-
quired during several stages of B cell development. For
example, IL-7 induces some of the steps of B cell differen-
tiation. These include the differentiation of CLPs into pre-
pro–B cells (13) and, by inducing expression of RAGs with
consequent construction of a functional 
 
  
 
chain locus, IL-7
promotes the differentiation of pro–B cells into pre–B cells
(14–18). IL-7 also supports the survival of some types of
developing B cells and can, in some cases, induce their pro-
liferation (4, 5). Once immature B cells have left the bone
marrow they cease to rely on IL-7 for survival or further
development. The survival of these more mature B cells is
controlled by ligands for the TNF receptor–related protein,
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CFSE, carboxyfluorescein diacetate succin-
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BAFF (also known as Tall-1, BLyS, THANK, and zTNF;
reference 19).
Some of these conclusions, however, are controversial.
This is for several reasons. First, in some cases, IL-7 can be
replaced by other factors. For example, in culture and in
very young mice, the effects of IL-7 on developing B
cells might be replaced by thymic stromal lymphopoetin
(TSLP), a cytokine that binds to a receptor related to that
for IL-7 (20, 21). However, no specific role for TSLP has
been identified and mice lacking the TSLP receptor have a
normal B lymphoid compartment (22). Second, in some
cases, IL-7 appears to act in conjunction with other stimuli.
For example, the effects of IL-7 on very early lymphocyte
precursors also involve fms like tyrosine kinase 3 (Flt3) or
IL-11 plus steel factor (23–25), and the effects of IL-7 on
the pro– to pre–B cell conversion are aided by signaling
through the pre–B cell receptor itself (26, 27). Third, be-
cause the development of B cell precursors deprived of IL-
7–driven signals is substantially blocked at a very early
stage, it precludes study of the effects of IL-7 on later stages
of B cell development. Finally, it is not always a simple
matter to distinguish between the effects of IL-7 on differ-
entiation versus its effects on B cell precursor survival and/
or proliferation.
To deal with this last phenomenon, investigators have
manipulated factors known to affect lymphocyte survival.
These factors include the antiapoptotic Bcl-2 family mem-
bers Bcl-2, a protein whose expression is increased by IL-7
signaling, and Bcl-xl, as well as their proapoptotic relative,
Bim. Overexpression of these two antiapoptotic proteins in
B cells has different consequences. Although the number of
pre–B cells increases in mice overexpressing Bcl-xl (28),
expression of Bcl-2 has no effects on B cell precursor num-
ber, but instead results in increased numbers of mature B
cells (29). Mice lacking Bim also contain three- to fourfold
more mature B cells than normal animals (30, 31). Because
of the potential of IL-7 to increase expression of antiapo-
ptotic Bcl-2 family members and the known interaction
between these survival factors and Bim, Bim could play a
role in mediating the death of B cells deprived of IL-7. In-
terestingly, it was recently shown that B cell precursors
from mice lacking Bim are resistant to death when cultured
in the absence of IL-7 (30). However, analysis of the role
of Bim in mediating the death of B cells deprived of IL-7 in
vivo has not been published.
To determine the relative effects of IL-7 on B cell pre-
cursor survival versus B cell precursor differentiation, we
chose to study the requirements for IL-7 in cells that do or
do not express Bim. Absence of Bim allows the survival of
some B cell precursors in the absence of IL-7 in vitro.
However, our results show that lack of Bim does not pro-
mote the conversion of lymphocyte precursors to pro–B
cells or the induction of IgM expression by pre–B cells.
Under conditions of limiting IL-7, B cell differentiation
continues, with B cells less likely to survive if they express
Bim, but not if they lack Bim. Thus, the number of imma-
ture B cells in animals is governed to a large extent by IL-7
and its ability to counteract the death-inducing effects of Bim.
 
Materials and Methods
 
Mice.
 
Homozygous Bim
 
    
 
mice were bred from mice pro-
vided by A. Strasser (The Walter and Eliza Hall Institute of Med-
ical Research, Victoria, Australia). The IL-7
 
    
 
mice were bred
from animals provided by V. von Freeden-Jeffry and R. Murray
(DNAX Research Institute of Molecular and Cellular Biology,
Palo Alto, CA; reference 32). All mice were backcrossed between
seven and nine generations to C57BL/6 mice purchased from
The Jackson Laboratory. All mice were maintained under patho-
gen-free conditions in the Biological Resource Center, National
Jewish Medical and Research Center, and were 4–16 wk old at
the beginning of each experiment unless otherwise noted. The
protocols used were in accordance with the guidelines drafted by
the National Jewish Medical and Research Center and the Insti-
tutional and Animal Care Use Committee.
 
Cell Sorting and Flow Cytometry Analysis.
 
For surface staining,
cell suspensions were incubated for 15 min on ice with anti–
mouse FcR-
 
 
 
2, 2.4G2 to prevent nonspecific binding of antibodies
to the Fc receptors on cells. Cells were then washed and incubated
on ice with mixtures of labeled antibodies as noted. Anti–mouse
antibodies (BD Biosciences) used for these experiments included
anti–CD2-PE, anti–CD21/CD35-FITC, anti–CD23-PE, anti–
CD24-biotin, anti–CD5-PE, anti–B220-APC or CyChrome, and
anti–IgM-FITC or anti–IgM-APC. The monoclonal hamster
anti–mouse Bim antibody, Ham 151-149, was made from a ham-
ster immunized with a complex of mouse Bim and Bcl-XL pro-
duced in insect cells. The antibody reacts in Western blots and
by immunofluorescence with permeabilized B and T cells from
Bim
 
   
 
, but not Bim
 
   
 
, mice. Cells were permeabilized with
0.03% saponin, incubated with 12.5 
 
 
 
g/ml Ham 151-149, washed
thoroughly, and then stained with PE- or APC-coupled anti–
hamster antibodies. After incubation with antibodies, cells were
sorted using a MoFlo machine (DakoCytomation) or analyzed on
a FACSCalibur machine. Subsequent analyses used CELLQuest
software (BD Biosciences) and FloJo (TreeStar).
 
Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) Labeling.
 
Cells were labeled with CFSE (Molecular Probes) as described pre-
viously (33). In brief, a stock solution of 5 mM CFSE in DMSO
was diluted at 1:10 in serum-free Spinner modified Eagle’s me-
dium (SMEM; Biosource International) that was prewarmed to
37
 
 
 
C. B cells were diluted to 5 
 
  
 
10
 
7 
 
cells/ml and incubated with
5 
 
 
 
M CFSE at 37
 
 
 
C for 10 min. Labeled cells were washed twice
with SMEM and placed in culture as described above.
 
Bone Marrow Culture.
 
Bone marrow cells were isolated and
cultured as described previously (34). In brief, bone marrow was
obtained from the femurs of 6–12-wk-old mice. A single cell sus-
pension was prepared, depleted of erythrocytes using buffered
ammonium chloride, washed twice in SMEM, and cultured at
5 
 
  
 
10
 
5 
 
cells/ml with 5 ml/well in a six-well Petri dish (7% CO
 
2
 
,
37
 
 
 
C) in SMEM containing 100 U/ml penicillin, 100 
 
 
 
g/ml
streptomycin, 50 
 
 
 
g/ml gentamicin, 2 mM 
 
l
 
-glutamine, 1 mM
sodium pyruvate, 50 
 
 
 
M 2-ME, 10% FBS (Oatlanta Biologicals),
and 50–100 U of IL-7 derived from culture supernatant of J558L
cells transfected with murine IL-7 cDNA (provided by A.
Rolink, University of Basel, Basel, Switzerland). Cells were cul-
tured for time points as noted in Fig. 2, washed twice with
SMEM, and used in subsequent experiments. Cell viability was
assessed using forward scatter and side scatter analysis on the
FACSCalibur cytofluorograph.
 
RNA Purification and Real-Time PCR Analyses.
 
RNA was
purified from bone marrow cells using Trizol (Life Technologies)
according to the manufacturer’s instructions. cDNAs were syn-
thesized using M-MLV reverse transcriptase according to the 
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manufacturer’s instructions (Life Technologies). cDNAs for IL-7
and actin were analyzed by real-time PCR using the TaqMan
PCR kit and an ABI 7700 sequence detector thermal cycler ac-
cording to the manufacturer’s instructions (Applied Biosystems),
and quantified with Sequence Detection Systems software 1.6.3
(Applied Biosystems). cDNAs were quantified using a real-time
PCR probe and primers previously described for IL-7 (35) and
actin (36). Analysis of negative control cDNA synthesis in reac-
tions lacking the M-MLV reverse transcriptase did not produce
signal within 40 cycles. Additionally, cDNA made from bone
marrow of IL-7
 
    
 
animals failed to produce a signal within 40
cycles, demonstrating that the IL-7 primers and probe are specific
for IL-7 cDNA. RNA levels quantified by these methods were
normalized to the levels of actin detected for each sample. All
samples were performed in triplicate.
 
Results
 
Bim Is Expressed at All Stages of B Cell Development.
 
We
wished to study whether loss of proapoptotic Bim would
allow developing B cells to endure IL-7 deprivation. For
either of these proteins to affect B cells directly, Bim must
be expressed within the cell and the receptor for IL-7 must
be expressed on the cell surface. The receptor for IL-7 is
expressed on developing B cells from the beginning of
lymphoid commitment to the immature B cell stage (37).
However, expression of Bim at different stages of B cell de-
velopment has not previously been evaluated. Therefore,
we isolated developing and mature B cells from bone mar-
row and spleens of control Bim
 
    
 
mice and their normal
Bim
 
    
 
littermates, stained them to identify the various B
cell developmental subsets, and stained Bim within the cells
using a hamster anti-Bim monoclonal antibody, Ham 151-
149, which we have produced (Fig. 1).
The anti-Bim antibody has good specificity for Bim be-
cause it stained B cells from Bim
 
    
 
animals very poorly
and mature B cells from Bim
 
    
 
animals well. Anti-Bim
stained all B cell precursors from Bim
 
    
 
animals more in-
tensely than the Bim
 
    
 
controls. However, the intensity of
staining with anti-Bim varied with the maturational state of
the B cell, with pre-pro–B cells barely registering above
background. Staining increased as the cells matured from
pro– and pre–B cells through the immature stage and was
Figure 1. Bim expression in bone marrow B cells. Bone marrow cells
isolated from wild-type and Bim    mice were stained with antibodies
against developmental stage-specific surface markers, and then permeabi-
lized and stained using the anti-Bim antibody Ham 151-149. (A) Bone
marrow cells were analyzed by flow cytometry to determine the expression
of Bim in pre-pro–B cells (B220  CD19  IgM ), pro– and pre–B cells
(B220  CD19  IgM ), immature B cells (B220  CD19  IgM ), and mature
recirculating B cells (B220hi CD19  IgMint). Bim    B cells were stained
as a negative control and are shown in solid gray. (B) Mean fluorescence
intensities of cells analyzed above are shown. Data are representative of
four individual experiments.
Figure 2. Loss of Bim allows developing B cells to survive in vitro in
the absence of IL-7. (A and B) Bone marrow cells were isolated from
Bim    and Bim    mice, sorted into B220  IgM  (pro– and pre–B) and
B220int IgM  (immature) populations, and cultured in the absence or
presence of exogenous IL-7. (A) Sorted B cells were counted and ana-
lyzed at 42 h by flow cytometry. Cells were assessed for percent of live
cells (live gated cells/total cell number) by forward versus side scatter
analysis. Hatched boxes represent cells cultured in the absence of IL-7,
whereas closed boxes represent cells cultured in the presence of IL-7.
(B) Sorted B cells were labeled with CFSE and cultured in the absence or
in the presence of IL-7 for 3 d. Cells were then analyzed by flow cytometry
for differentiation (as determined by expression of IgM) and proliferation
(loss of CFSE). 
Bim
 
    
 
B Cells Do Not Develop in IL-7
 
    
 
Mice
 
1182
highest in mature cells recirculating through the marrow
(Fig. 1, A and B). These results show that Bim is expressed
to some extent at all stages of B cell development and that
expression increases with the maturity of the B cell. There-
fore, Bim might affect the survival of all of these subsets.
 
The Death of Early B Cells Induced by Lack of IL-7 Is
Caused by Bim.
 
It has been reported previously that lack of
Bim promotes survival of pre–B cells in the absence of IL-7
in vitro (30). To confirm this result and examine the effects
of Bim in survival of developing B cells deprived of IL-7, we
isolated B220
 
  
 
IgM
 
  
 
pro– and pre–B cells and immature B
cell precursors from Bim
 
    
 
and Bim
 
    
 
mice and cultured
them in the absence or presence of IL-7. Cultures were then
harvested and B cell survival was monitored (Fig. 2 A).
In the absence of IL-7, 
 
 
 
40% of Bim
 
    
 
pro– and pre–B
cells died within the first 48 h. Cell death was reduced if
these cells were cultured in the presence of IL-7 or if they
did not express Bim. The rate of death of the Bim
 
    
 
pro–
and pre–B cells was unaffected by IL-7. The rate of death
of immature B cells was unaffected by the presence of IL-7.
Bim
 
    
 
immature B cells were just as likely to die if IL-7
were present in the culture medium than if it were not.
Again, loss of Bim allowed immature B cells to survive
without additional cytokine. Thus, our data suggest that
Bim is required for death of developing B cells deprived of
cytokines. In the case of immature B cells, this is not due to
lack of IL-7. It is not surprising that immature B cells do
not respond to IL-7 because these cells have low expression
of the IL-7R
 
  
 
(37, 38) and their survival is governed by
Baff (19).
Although a straightforward interpretation of the results in
Fig. 2 A suggests that IL-7 operates to counteract the death-
promoting effects of Bim in pro– and/or pre–B cells, this
interpretation is complicated by the fact that IL-7 can pro-
mote development of these subsets of B cells. To begin to
dissect these events and determine whether lack of Bim
could affect the requirement for IL-7 in pro– and pre–B cell
development, we isolated B220
 
  
 
IgM
 
  
 
B cells from Bim
 
   
 
and Bim
 
    
 
mice, labeled the cells with CFSE, and cultured
them in the absence or presence of IL-7. After 3 d, we ana-
lyzed the cells for proliferation, as assessed by loss of CFSE,
and for differentiation into cells expressing IgM, an event
that is known to involve IL-7 (13, 14). As shown in Fig. 2
B, the sorted cells did not divide or differentiate unless IL-7
was present. Additionally, the requirements for IL-7 for dif-
ferentiation and proliferation were unaffected by expression
of Bim. Overall, these results show that IL-7 and Bim coun-
teract each other’s effects on the survival of pro– and pre–B
cells. However, survival alone (promoted by the absence of
Bim) is not enough to permit differentiation to IgM expres-
sion and proliferation. As reported previously (12–14), IL-7
is needed to induce these latter phenomena.
 
Absence of Bim Does Not Substitute for IL-7 in the Conver-
sion of CLPs to Pro–B Cells.
 
IL-7 is needed to promote dif-
ferentiation at very early stages of B cell development, in the
conversion of CLPs to pro–B cells and at the conversion of
pro– to immature B cells (12–14, 16). To find out whether
lack of Bim can substitute for IL-7 in these events, we com-
pared the number of B cells at various developmental stages
in the bone marrow of mice expressing or lacking IL-7 and
Figure 3. Lack of Bim has no effect on the block in B cell
development caused by the absence of IL-7. (A) Bone marrow
cells from 6-wk-old wild-type IL-7    Bim    and IL-7   
Bim    mice were stained with B cell developmental stage-
specific markers and analyzed by flow cytometry. Pro– and
pre–B cells are indicated by box 1 (B220  IgM ), whereas
immature B cells and mature recirculating B cells are indicated
by boxes 2 (B220  IgM ) and 3 (B220hi IgMint), respectively.
(B) To further delineate the early B cell subsets, cells were
gated through box 1 and analyzed for expression of CD19
and CD2. Boxes 4, 5, and 6 depict pre-pro–B, pro–B, and
pre–B cells, respectively. Box 7 indicates a population that
lacks expression of B cell lineage markers CD19 and IgM,
and thus probably represents a B220  B lineage  cell. (C) The
total number of B cells in the developmental subfractions
was determined for each genotype. Numbers represent
cells   10–5 collected from one femur per mouse (n   4/
genotype). Error bars represent SEM. 
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in mice expressing or lacking Bim. Bone marrow cells were
isolated from 6-wk-old mice and stained with antibodies
against B220, IgM, CD19, and CD2. Immature and mature
B cells, identified as cells bearing IgM and intermediate and
high levels of B220, respectively (1), could readily be identi-
fied in IL-7
 
    
 
Bim
 
    
 
mice (Fig. 3 A, populations 2 and 3).
These cells were found at very low percentages in mice lack-
ing IL-7 whether or not the cells also expressed Bim. Like-
wise, cells expressing B220 but not IgM, most of which are
pro– and pre–B cells (1), were present in IL-7
 
    
 
animals and
strikingly deficient in mice lacking IL-7 (Fig. 3 A, population
1). Again, absence of Bim had no effect on this deficit.
Several types of bone marrow cells, including several
types of B cell precursors, bear B220 but not IgM (1). To
find out if lack of Bim affected any of these populations in
IL-7–deficient mice, we analyzed the B220
 
  
 
IgM
 
  
 
cells in
more detail. B220
 
  
 
IgM
 
  
 
bone marrow cells from IL-7
 
   
 
animals contained substantial numbers of CD19
 
  
 
CD2
 
 
 
pro–B cells and CD19
 
  
 
CD2
 
  
 
pre–B cells (Fig. 3 B and C,
populations 5 and 6; reference 39). These cells were at very
low percentages in mice lacking IL-7 and, again, their
numbers were not affected by lack of Bim.
These results were perhaps not surprising because lack of
IL-7 has recently been reported to interrupt B cell develop-
ment at the time of conversion of B220
 
  
 
CLPs to B220
 
 
 
pre-pro–B cells. Obviously, a block at this stage would in-
hibit all downstream events. Therefore, we were particu-
larly interested in the effects of Bim deficiency on the very
earliest B cell precursor cells, the B220
 
  
 
IgM
 
  
 
CD19
 
 
 
CD2
 
  
 
cells in bone marrow (Fig. 3 B, population 4). The
number of these cells was unaffected by the presence or ab-
sence of IL-7 or Bim (Fig. 3, B and C). These cells include
non–B lineage cells in addition to pre-pro–B cells (1). So it
is difficult to interpret the absence of an effect of IL-7 defi-
ciency in these cells. It appears clear, however, that in the
absence of IL-7, there is a block in lymphocyte develop-
ment during the conversion of CLPs to pro–B cells that it
is not influenced by the loss of proapoptotic Bim.
A final population of cells, bearing B220 and CD2 but
lacking IgM and CD19, is also evident in Fig. 3 B (popula-
tion 7). These cells express neither the granulocyte marker,
GR1, nor the 
 
  
 
chain of the T cell receptor (not depicted),
and their numbers are unaffected by the absence of IL-7 or
Bim. Taken together with the data presented earlier in this
paper, these results suggest that IL-7 promotes early B cell
differentiation in at least two stages: during the conversion
of CLPs to pro–B cells and at the conversion of pro–B cells
to pre– and immature B cells. Lack of Bim does not substi-
tute for IL-7 in either process.
 
Lack of Bim Increases the Rate at Which Mature B Cells Ac-
cumulate in IL-7
 
    
 
Mice.
 
Mature splenic B cells appear in
very low numbers in mice lacking IL-7 or lacking the abil-
ity to signal via the IL-7 receptor (9–12), whereas B-1–type
B cells are unaffected by IL-7 deficiency. To determine
whether the absence of Bim would modify the number of
cells that could accumulate at the mature B cell stage in the
absence of IL-7, we analyzed B cells in the spleens and
peritoneal lavage fluid of mice lacking IL-7 with or with-
out Bim, and in the spleens of wild-type animals.
In normal animals, mature, follicular B cells increased
somewhat in number as mice aged from 4 to 6 wk and re-
mained constant between 6- and 12-wk-old wild-type
mice (Fig. 4). As previously reported (9), the spleens of IL-
7–deficient animals contained very few mature B cells.
Their numbers increased slightly as the mice aged. In IL-7–
deficient mice, the number of mature B cells was increased
if the cells also lacked Bim. The differential between IL-7
 
   
 
B cells expressing or lacking Bim became more evident
with increasing age. Peritoneal B-1a cells were unaffected
by loss of either IL-7 or Bim (Fig. 4).
The development of marginal zone B cells has been re-
ported to be relatively resistant to the absence of IL-7 (40,
41). Therefore, we analyzed the number of these cells. As
expected, lack of IL-7 had much less effect on the number
of marginal zone B cells than on mature B cells (Fig. 4).
Even so, marginal zone B cells were reduced by 
 
 
 
75% in
number in the spleens of 4-wk-old IL-7–deficient animals,
although they gradually increased thereafter (Fig. 4). Ab-
sence of Bim increased these numbers somewhat, but did
not restore their numbers to those in wild-type animals.
These results indicate that even though there is no de-
monstrable effect of the absence of Bim on the number of
B cells at any stage of development in IL-7
 
    
 
mice, lack of
Bim can to some extent compensate for lack of IL-7, as far
as the number of mature B cells are concerned. This could
be due to a very subtle effect of Bim on the number of B
cell precursors that can develop independently of IL-7. Al-
ternatively, lack of Bim could prolong the life span of B
cells that have managed to develop in the absence of IL-7.
 
Bim
 
    Cells Survive and Develop Better Than Bim    Cells
When IL-7 Is Limiting. Experiments have shown that
availability of IL-7 in normal animals limits the number of
Figure 4. Follicular B cells in IL-7    Bim   
animals accumulate as mice age, but their num-
bers are fewer than in wild-type mice. Splenic
and peritoneal B cells from 4–12-wk-old wild-
type ( ), IL-7    Bim    ( ), and IL-7    Bim   
( ) mice were analyzed by flow cytometry.
B220  IgM  CD5  cells representing B-1a B cells
from the various genotypes are depicted on the
right. The total number of spleen cells characteristic
of marginal zone (B220  CD21hi CD23 ) or follic-
ular B cells (B220  CD21int CD23 ) is shown on
the middle and left panels, respectively. n   4–6
animals per group and error bars are SEM.Bim    B Cells Do Not Develop in IL-7    Mice 1184
B cells that are produced. For example, administration of
IL-7, or overexpression of the gene for IL-7, increases the
number of B cells in mice (42, 43). In old mice, IL-7 levels
in the bone marrow decrease and B cell production is di-
minished (44–45). The experiments described above and
elsewhere show that IL-7 is needed both for survival of
early B cells and, at several stages, for their differentiation.
Our in vitro experiments also show that IL-7 governs sur-
vival of early B cells and that at the stages where this applies,
survival in the absence of IL-7 can be achieved by lack of
Bim. These results lead us to ask whether differentiation or
survival of B cells is more affected by low levels of IL-7.
To answer this question we bred mice expressing or
lacking Bim and heterozygous for the IL-7 deficiency. To
determine whether IL-7 is more limiting in IL-7    mice
than in wild-type animals, we performed real-time PCR
analysis on bone marrow from IL-7   , IL-7   , and IL-7   
mice. We measured IL-7 message and normalized its levels
to those of actin. Fig. 5 A shows that the level of IL-7
mRNA in IL-7    bone marrow is 60% of that detected in
IL-7    marrow. Therefore, gene dosage does have an ef-
fect on IL-7 mRNA levels and probably (although this is
very difficult to measure in vivo) on IL-7 protein levels.
Next, to determine whether limiting IL-7 had a func-
tional consequence in vivo, we analyzed the number of B
cells at various developmental stages in the bone marrows
and spleens of these animals, and control wild-type mice.
The results are shown in Fig. 5 B and summarized in Fig. 5
C. As before, bone marrow from wild-type mice contained
B cells at all stages of development, and bone marrow from
IL-7    Bim    mice contained normal numbers only of
B220  IgM  cells (Fig. 5 B, population 1). Bone marrow
from mice expressing limiting amounts of IL-7 and wild-
type levels of Bim, the IL-7    Bim    animals, con-
tained normal numbers of B220  CD19  CD2  IgM 
cells and about half the number of developing B cells at
all later stages compared with wild-type animals. Strik-
ingly, however, bone marrow from IL-7    Bim    ani-
mals contained normal numbers of B cells at all stages of
development.
Not surprisingly, survival and differentiation in the bone
marrow was followed by transport to and accumulation in
the spleen. Thus, the spleens of young IL-7    Bim    ani-
mals contained normal numbers of mature B cells, whereas
these cells were at half normal numbers in the spleens of
IL-7    Bim    mice (not depicted). Because lack of Bim
overcame the partial deficiency of IL-7 in IL-7    animals,
and Bim affects only the survival of B cells, these results
suggested that for early B cells, survival is more dependent
on IL-7 levels than on differentiation.
Discussion
IL-7 is clearly very important for many processes that oc-
cur during B cell development. It guides the differentiation
of B cell precursors through at least two stages, the conver-
sion of CLPs to pro–B cells, and the conversion of pro– to
pre–B cells. IL-7 also promotes survival and proliferation at
several stages of B cell development. Given the many phe-
nomena associated with IL-7, the interactive effects of the
proapoptotic factor Bim and IL-7 were unpredictable.
Here, we show that Bim probably does not affect any of
the differentiation events induced by IL-7 signaling. B cell
development is blocked at a very early stage in mice lacking
IL-7 and the blockage is not circumvented by the absence
Figure 5. Bim    B cells survive and develop better in limiting IL-7
than their Bim    counterparts. (A) Limiting dilution real-time PCR
analysis of total bone marrow cells from IL-7   , IL-7   , and IL-7   
mice. IL-7 mRNA was normalized to levels of actin mRNA for each
sample. Samples were run in triplicate from two to four mice per geno-
type. (B) Bone marrow cells from wild-type, IL-7    Bim   , IL-7   
Bim   , and IL-7    mice were isolated and developing B cell subsets
were analyzed by flow cytometry as detailed previously (Fig. 3). (C) Total
cell numbers within each subset were determined. Numbers of cells in
each subset were then normalized to numbers obtained from wild-type
mice. IL-7    Bim    cells are depicted by open bars, IL-7    Bim    by
closed bars, and IL-7    Bim    cells are represented by striped bars (n   3/
genotype and error bars show SD).Oliver et al. 1185
of Bim, even though in wild-type mice, cells at these very
early stages express Bim, albeit at very low levels. Thus, ei-
ther IL-7 does not induce survival signals at this stage, sur-
vival alone is not sufficient to drive conversion of CLPs to
pro–B cells, or Bim is not the apoptotic protein crucial for
death at this stage.
Likewise, IL-7 induces the differentiation of pro– and
pre–B cells to the immature B cell stage and consequent
IgM expression (14–16). Again, lack of Bim was not suffi-
cient to induce this differentiation event, nor would it al-
low proliferation of B cell precursors, although lack of Bim
did allow survival of the pre–B cells in the absence of IL-7.
Thus, simply staying alive is not enough to allow differenti-
ation of the cells. Additional signals are required, and these
signals are delivered via the IL-7 receptor.
It is interesting to compare the effects on survival and
lack of effects on differentiation and proliferation of Bim
and the various antiapoptotic proteins expressed in early B
cells. B cell development is fairly normal in at least young
mice lacking Bcl-2 (46). Conditional knockout, at the
point at which early B cells start to express CD19 (pro–B
cells), of the gene coding for the antiapoptotic protein
Mcl-1 causes the death of B cells at that stage (47). This is
one of the stages at which lack of Bim compensates for lack
of IL-7. Hence, it is likely that in pro–B cells, IL-7 allows
survival by inducing Mcl-1 (47) and the Mcl-1 counteracts
the death-inducing effects of Bim. In the absence of Bim,
IL-7 and its downstream effector Mcl-1 are not required
for survival. Overall, the results here suggest that Bim and
IL-7 balance each other’s effects on B cell progenitor sur-
vival. However, survival alone is not sufficient to allow B
cell precursor differentiation from CLPs to pro–B cells, or
from pro– to immature B cells. IL-7 itself is needed for
these events.
The data presented here do allow us to draw some con-
clusions about the relative need for IL-7 signaling for dif-
ferentiation versus survival. The number of B cells at most
maturational stages are about half those in wild-type ani-
mals in mice that are heterozygous for IL-7 expression.
This suggests that levels of IL-7 are accurately reflected in
the number of B cells and their precursors. This effect
could be due to control by IL-7 on rates of differentiation,
on rates of proliferation, or on survival of B cell precursors.
The results presented here suggest that levels of IL-7 affect
most predominantly the survival of B cell precursors. This
interpretation is suggested by the fact that absence of Bim
allows normal numbers of B cell precursors and B cells to
appear in mice in which IL-7 is limiting, and Bim is known
to affect cell survival, not cell proliferation or, as shown
here, cell differentiation.
Why would B cell survival be more sensitive to low lev-
els of IL-7 than B cell differentiation or proliferation? This
could be explained in several ways. First, in developing B
cells, a brief “hit” by IL-7 might be sufficient to drive dif-
ferentiation or proliferation signals, whereas survival may
require IL-7 to be continuously present. Thus, when IL-7
is limiting, the cells might be intermittently deprived of
this life-giving cytokine and thus more likely to die. Alter-
natively, the observations reported here may suggest that
low levels of continuous signaling via the IL-7 receptor are
sufficient to induce differentiation and proliferation, but
not survival. Others have shown that IL-7 acts with other
factors at some stages of B cell development. For example,
in normal mice, IL-7 and Flt3 ligand act together to stim-
ulate CLP differentiation to pro–B cells (23). Later in B
cell development, the pre–B cell receptor and IL-7 act
synergistically to promote further differentiation of pre–B
cells, and signaling through the pre–B cell receptor in-
creases the ability of the cell to detect signaling via the IL-7
receptor (27). Therefore, perhaps the greater sensitivity of
precursor B cell survival versus differentiation to IL-7 re-
flects the (untested) idea that survival is stimulated solely
by IL-7, whereas other factors act together with IL-7 to pro-
mote differentiation.
IL-7–deficient mice are profoundly lacking in mature B
cells. Lack of Bim counteracts this deficiency to some ex-
tent. This could be due to subtle effects of lack of Bim on
cell precursors. For example, in the absence of IL-7, Bim   
pro– and pre–B cells might convert to immature B cells at
a slightly higher rate than Bim    pro– and pre–B cells,
thus slowly giving rise to a larger number of mature B cells
as mice age. If this conclusion is correct, it would suggest
that survival time is related to the probability that a B cell
precursor will convert to the next stage in its development,
in the absence of any other signal. However, it is more
likely that mature B cells accumulate in the absence of IL-7
if they also lack Bim because Bim is involved in the sur-
vival of mature B cells themselves. Isolated mature B cells
from normal mice die fairly rapidly in the absence of
BlySS/BAFF in culture, whereas mature B cells lacking
Bim have a long survival time when cultured in the same
manner (unpublished data). It is likely that this could reflect
a longer survival time for mature B cells in animals. Hence,
in IL-7–deficient mice, mature B cells probably accumulate
more rapidly if they also lack Bim because lack of Bim pro-
motes the survival of the mature B cells themselves.
Overall, however, the results presented here show that
Bim is expressed at most stages of B cell development and
that Bim and IL-7 counteract each other’s actions in pro-
moting the death versus the survival of B cell precursors at
several stages of development. Bim acts solely to affect B
cell survival, however, and does not directly affect B cell
proliferation or differentiation. Hence, the balance be-
tween Bim and IL-7 is crucial to the control of B cell pre-
cursor survival and thus total B cell number.
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